Rafferty Asset Management, LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 55 filers reported holding PROQR THRAPEUTICS N V in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2023$46,178
-83.2%
21,680
-92.9%
0.00%
-100.0%
Q1 2022$275,000
-90.0%
303,356
-11.3%
0.00%
-85.7%
Q4 2021$2,740,000
-38.2%
342,083
-35.4%
0.01%
-53.3%
Q3 2021$4,435,000
+12.3%
529,883
-9.5%
0.03%
+20.0%
Q2 2021$3,948,000585,8060.02%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 2,401,570$14,602,0002.94%
DAFNA Capital Management LLC 1,237,400$7,523,0002.17%
RTW INVESTMENTS, LP 4,902,785$29,809,0000.84%
Kerrisdale Advisers, LLC 453,182$2,755,0000.31%
COWEN AND COMPANY, LLC 300,042$1,824,0000.30%
Artal Group S.A. 1,259,177$7,656,0000.21%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$27,664,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 221,360$1,346,0000.06%
FRANKLIN STREET ADVISORS INC /NC 60,000$365,0000.04%
JENNISON ASSOCIATES LLC 2,625,514$15,963,0000.01%
View complete list of PROQR THRAPEUTICS N V shareholders